PharmiWeb
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
FRAMINGHAM, MA / ACCESSWIRE / November 13, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology ...
2 days ago